California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...
The state's insulin—sold under the brand name CalRx—will be available at a recommended price of $11 per pen, or $55 for a ...
The pens are part of an initiative to “fundamentally lower health care costs, not spread” them, Gov. Gavin Newsom said.
Nido, short for Neat Insulin Daily Organiser, makes insulin injections safer and more convenient for persons with diabetes.
Biocon Biologics recently announced that it would manufacture and supply insulin glargine pens to Civica under a multi-year ...
This is read by an automated voice. Please report any issues or inconsistencies here. Gov. Gavin Newsom said $11 insulin pens will soon be available through the state’s pharmaceutical label.
California will offer CalRx-branded biosimilar insulin glargine pens for $11 per pen beginning January 1, 2026.
Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a Cedars-Sinai pharmacy in Los Angeles on Thursday. The effort is part of ...
California will soon become the first state to offer its own affordable insulin, with Gov. Gavin Newsom announcing that CalRx ...
California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.